-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-08-12
This 2025 review integrates tumor hypoxia, metabolic reprogramming, nutrient competition, and immune dysfunction into a unified model of immunosuppressive tumor microenvironment formation. Its practical value lies in identifying linked metabolic and oxygen-regulated processes that may guide biomarker development, experimental design, and combination therapies, while emphasizing that most proposed interventions remain context-dependent.
-
Dimethyloxalylglycine (DMOG) Workflow Guide
2026-08-12
Dimethyloxalylglycine (DMOG) provides a practical chemical perturbation for hypoxia-inducible factor stabilization in cell-based oxygen-sensing, hypoxia signaling, and inflammation studies. It is intended for controlled scientific research, not diagnostic, therapeutic, or clinical use, and results depend on solvent handling, matched controls, exposure design, and model-specific validation.
-
Mdivi-1: Selective DRP1 Inhibitor Guide
2026-08-11
Mdivi-1 is a cell-permeable, selective DRP1 inhibitor used to study mitochondrial fission, apoptosis, and mitochondrial dynamics. Product and disease-model evidence supports its use as a mechanistic perturbation, while formulation, dose translation, and pathway-specific interpretation remain important limitations.
-
Arachidonic Acid and Faster Vaccine-Induced Immunity
2026-08-10
A recent study shows that dietary arachidonic acid can strengthen rabies vaccine-induced humoral immunity in mice and accelerate neutralizing antibody development in human volunteers. Its mechanistic analysis links lymph-node arachidonic acid metabolism to prostaglandin I2 signaling, CD86 expression, and activation-induced cytidine deaminase in B cells.
-
Isoproterenol Sulfate Dihydrate in Pacemaker Assays
2026-08-09
Isoproterenol sulfate dihydrate provides a controlled beta-adrenergic challenge for human pacemaker and neuro-cardiac models. This article explains how to use it to separate receptor-driven physiology from innervation-associated maturation in SAN-plexus assembloid assays.
-
Spiroplasma Entry into S2 Cells: Endocytic Pathways
2026-08-08
Wei and colleagues established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris invades invertebrate-derived cells through clathrin-mediated endocytosis and macropinocytosis. Pharmacological inhibition, membrane perturbation, and cytoskeletal disruption together provide a useful framework for dissecting bacterial entry while clarifying the limits of interpreting chlorpromazine as a pathway-selective probe.
-
Camptothecin Workflows for DNA Damage Research
2026-08-07
Camptothecin combines a defined topoisomerase I lesion with practical readouts for DNA damage, cell death, senescence, and autophagy. This guide translates its use into reproducible cell-based workflows while showing how the 2026 prion-mutagenesis study can inform, but not replace, careful adaptive-evolution assay design.
-
Innovations in Histological Detection: Alcian Blue & Nuclear
2026-08-07
Explore the advanced chemistry and practical advantages of the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5, for mucopolysaccharide detection and chondrogenic differentiation. This article delivers a detailed technical perspective and highlights unique methodology insights for superior histological outcomes.
-
Sulfamonomethoxine: Applied Protocols for Veterinary and Aqu
2026-08-06
Sulfamonomethoxine (SMM) is a broad-spectrum antibiotic that uniquely bridges veterinary, aquaculture, and environmental research. This guide translates recent toxicity findings into robust workflows, troubleshooting strategies, and protocol enhancements for both antimicrobial and eco-toxicological applications.
-
CP-673451: Selective PDGFRα/β Inhibitor Empowering Cancer Re
2026-08-06
CP-673451 stands out as a highly selective PDGFRα/β inhibitor, enabling precise dissection of angiogenesis and tumor progression in advanced cancer models. Recent studies highlight its unique value in ATRX-deficient glioma workflows, with robust guidance for assay optimization and troubleshooting.
-
Bafilomycin C1: Applied Workflows for Autophagy and Cell Hea
2026-08-05
Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, is pivotal for dissecting autophagy, lysosomal function, and cell viability in translational research. This guide translates advanced protocols and troubleshooting strategies into actionable steps for high-content phenotypic screening and disease modeling.
-
Hexose Diphosphate in Metabolic Assays: Protocols and Pitfal
2026-08-05
Hexose diphosphate empowers researchers to dissect energy homeostasis and inflammatory pathways with precision, especially in cardiovascular ischemia and metabolic flux studies. This guide details application-driven workflows, troubleshooting strategies, and leverages cutting-edge insights from recent aging and inflammation research.
-
BAPTA Calcium Chelator: Applied Workflows in Cell Signaling
2026-08-04
BAPTA’s high-affinity calcium chelation enables precise dissection of calcium-dependent apoptosis under complex environmental exposures. From protocol optimization to troubleshooting, discover how APExBIO’s BAPTA empowers advanced cell signaling studies.
-
Leucovorin Calcium: Next-Gen Folate Rescue in Patient-Derive
2026-08-04
Explore how Leucovorin Calcium enables advanced, physiologically relevant folate metabolism and methotrexate rescue studies in patient-derived cancer assembloid models. Gain actionable insights into optimizing experimental design and overcoming antifolate drug resistance.
-
Angiotensin II: Applied Protocols for Vascular Remodeling Re
2026-08-03
Harness the power of Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) for advanced modeling of hypertension and vascular smooth muscle cell phenotypic switching. This guide distills validated workflows, troubleshooting tactics, and recent mechanistic insights to help you optimize cardiovascular and aneurysm studies using APExBIO's rigorously characterized reagent.
448 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page